CM313
Phase 2- Indications
- Immune thrombocytopenic purpura, Systemic lupus erythematosus, Multiple myeloma
Company intelligence / Profile preview
Mountainfield Venture Partners is a San Diego-based venture creation firm that builds and funds new biopharmaceutical companies around in-licensed, development-stage drug candidates. The team has deep experience forming biotech startups that have led to multiple FDA approvals and IPOs. The firm leverages its network of top-tier institutional investors and leadership teams to launch transformative medicines through newly created entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mountainfield Venture Partners.